Articles with public access mandates - AndrechekLearn more
Not available anywhere: 2
Effective personalized therapy for breast cancer based on predictions of cell signaling pathway activation from gene expression analysis
JR Jhan, ER Andrechek
Oncogene 36 (25), 3553-3561, 2017
Mandates: US National Institutes of Health, Susan G. Komen
How to choose a mouse model of breast cancer, a genomic perspective
MR Swiatnicki, ER Andrechek
Journal of mammary gland biology and neoplasia 24 (3), 231-243, 2019
Mandates: US National Institutes of Health
Available somewhere: 38
Anchorage-independent cell growth signature identifies tumors with metastatic potential
S Mori, JT Chang, ER Andrechek, N Matsumura, T Baba, G Yao, JW Kim, ...
Oncogene 28 (31), 2796-2805, 2009
Mandates: US National Institutes of Health
Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation
SY Lunt, V Muralidhar, AM Hosios, WJ Israelsen, DY Gui, L Newhouse, ...
Molecular cell 57 (1), 95-107, 2015
Mandates: US National Institutes of Health, Research Foundation (Flanders), Damon …
NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors
X Zhou, D Hollern, J Liao, E Andrechek, H Wang
Cell death & disease 4 (3), e560-e560, 2013
Mandates: US National Institutes of Health
Triple-negative breast cancer and the potential for targeted therapy
JR Jhan, ER Andrechek
Pharmacogenomics 18 (17), 1595-1609, 2017
Mandates: US National Institutes of Health
The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer
DP Hollern, J Honeysett, RD Cardiff, ER Andrechek
Molecular and cellular biology, 2014
Mandates: US National Institutes of Health, Susan G. Komen
Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data
K Liu, PA Newbury, BS Glicksberg, WZD Zeng, S Paithankar, ...
Nature communications 10 (1), 2138, 2019
Mandates: US National Institutes of Health
Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential
ER Andrechek, RD Cardiff, JT Chang, ML Gatza, CR Acharya, A Potti, ...
Proceedings of the National Academy of Sciences 106 (38), 16387-16392, 2009
Mandates: US National Institutes of Health
Immunogenic subtypes of breast cancer delineated by gene classifiers of immune responsiveness
LD Miller, JA Chou, MA Black, C Print, J Chifman, A Alistar, T Putti, X Zhou, ...
Cancer immunology research 4 (7), 600-610, 2016
Mandates: US National Institutes of Health
A genomic analysis of mouse models of breast cancer reveals molecular features ofmouse models and relationships to human breast cancer
DP Hollern, ER Andrechek
Breast Cancer Research 16, 1-16, 2014
Mandates: US National Institutes of Health, Susan G. Komen
The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment
J Turpin, C Ling, EJ Crosby, ZC Hartman, AM Simond, LA Chodosh, ...
Oncogene 35 (47), 6053-6064, 2016
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
E2F1 drives breast cancer metastasis by regulating the target gene FGF13 and altering cell migration
DP Hollern, MR Swiatnicki, JP Rennhack, SA Misek, BC Matson, ...
Scientific reports 9 (1), 10718, 2019
Mandates: US National Institutes of Health, Worldwide Cancer Research, UK
Estrogen-regulated feedback loop limits the efficacy of estrogen receptor–targeted breast cancer therapy
T Xiao, W Li, X Wang, H Xu, J Yang, Q Wu, Y Huang, J Geradts, P Jiang, ...
Proceedings of the National Academy of Sciences 115 (31), 7869-7878, 2018
Mandates: US Department of Defense, US National Institutes of Health, National …
Histological subtypes of mouse mammary tumors reveal conserved relationships to human cancers
DP Hollern, MR Swiatnicki, ER Andrechek
PLoS genetics 14 (1), e1007135, 2018
Mandates: US National Institutes of Health, Worldwide Cancer Research, UK
Patterns of cell signaling pathway activation that characterize mammary development
ER Andrechek, S Mori, RE Rempel, JT Chang, JR Nevins
Oxford University Press for The Company of Biologists Limited 135 (14), 2403 …, 2008
Mandates: US National Institutes of Health
HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors
ER Andrechek
Oncogene 34 (2), 217-225, 2015
Mandates: US National Institutes of Health
Chordin-like 1 suppresses bone morphogenetic protein 4-induced breast cancer cell migration and invasion
C Cyr-Depauw, JJ Northey, S Tabariès, MG Annis, Z Dong, S Cory, ...
Molecular and Cellular Biology 36 (10), 1509-1525, 2016
Mandates: Canadian Cancer Society, Fonds de recherche du Québec - Santé, Worldwide …
Integrated analyses of murine breast cancer models reveal critical parallels with human disease
JP Rennhack, B To, M Swiatnicki, C Dulak, MP Ogrodzinski, Y Zhang, C Li, ...
Nature communications 10 (1), 3261, 2019
Mandates: US National Institutes of Health, Worldwide Cancer Research, UK
Functional redundancy between β1 and β3 integrin in activating the IR/Akt/mTORC1 signaling axis to promote ErbB2-driven breast cancer
T Bui, J Rennhack, S Mok, C Ling, M Perez, J Roccamo, ER Andrechek, ...
Cell reports 29 (3), 589-602. e6, 2019
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
Publication and funding information is determined automatically by a computer program